90 research outputs found
Group exercise class for people with chronic stroke: A service improvement programme
Introduction: Individuals with stroke are less physically active and have increased risk of secondary problems such as weakness, fear of falls, loss of confidence, social isolation and depression leading to increased disability. Group exercise classes have shown beneficial effects in people with neurological conditions. The aim of this pilot work was to assess the benefits of group exercise class in people with chronic stroke. Methods: People with chronic stroke were recruited from the community. Pre and post rehabilitation outcomes included: Timed up and Go (TUG), Berg Balance Scale (BBS) Score, Motor Assessment Scale (MAS-upper limb section), and patients/family memberâs perception of perceived benefits. Patientsâ received 8 weeks (1 hour/week) of group exercise class which included warm up and flexibility exercises in sitting, dynamic balance exercises, gait re-education and upper limb exercises. Patients were encouraged to maintain a diary of exercises / activities practiced at home. Results: Ten patients (8 men / 2 women) with mean age 53±8 years were included in the exercise class. Compliance was good and 2 patients missed 2 sessions due to prior medical appointments. Pre and post rehabilitation measurements showed mean difference of 1.5 seconds on TUG and 4 points on BBS but no difference for MAS score. Both patients and family members reported following benefits: socialisation, increased confidence in mobility, increase in distance walked outdoor and more engagement with exercises. Conclusion: The 8 weeks of group exercise programme showed some improvement in balance, mobility and confidence in people with chronic stroke. The other perceived benefits included motivation and socialisation
Low digestible starch and food industry: A changing paradigm
Globally, starch based foods including staples are consumed most as they contribute maximum towards the daily per capita energy. While the carbaholic nature resulting high post prandial glycemic response has led to a starch dilemma and innovative low glycemic profile grains as well as products are thus the need of the hour. The presence of two nutritional fractions â slowly digestible starch (SDS) and resistant starch (RS) which endorse the low glycemic potency is thus supplemented in food industry for developing low glycemic food prototypes. The unique characteristic of RS like bland flavour, white colour, low water holding capacity along with its prebiotic potential has made them a valuable component in functional foods. Many strategies are currently applied to increase the proportion of SDS and RS including physical, chemical, enzymatic as well as their combinations. Thus, considering the changing paradigm, the aim of this review is to understand the basic concepts of starch digestibility, inherent factors affecting digestibility, applications in food industry, current strategies, commercial counterparts as well as existing dietary regulations
Low digestible starch and food industry: A changing paradigm
830-841Globally, starch based foods including staples are consumed most as they contribute maximum towards the daily per capita energy. While the carbaholic nature resulting high post prandial glycemic response has led to a starch dilemma and innovative low glycemic profile grains as well as products are thus the need of the hour. The presence of two nutritional fractions â slowly digestible starch (SDS) and resistant starch (RS) which endorse the low glycemic potency is thus supplemented in food industry for developing low glycemic food prototypes. The unique characteristic of RS like bland flavour, white colour, low water holding capacity along with its prebiotic potential has made them a valuable component in functional foods. Many strategies are currently applied to increase the proportion of SDS and RS including physical, chemical, enzymatic as well as their combinations. Thus, considering the changing paradigm, the aim of this review is to understand the basic concepts of starch digestibility, inherent factors affecting digestibility, applications in food industry, current strategies, commercial counterparts as well as existing dietary regulations
Striking Deals : Concertation in the Reform of Continental European Welfare States
The reform of the welfare state entails changes in interdependent policy fields
stretching from social policies to employment and wage policies. These linked
policy fields are often governed by varying sets of corporate actors and involve
different decision making procedures. Adaptation in one policy field is often uncoordinated
with other policies, and can work at cross-purposes, produce negative
externalities, or fail due to missing supporting conditions. The paper has two
objectives. It first argues that renewed emergence of tripartite concertation is due
to the need to co-ordinate policies across policy fields. Second, it evaluates the
institutional factors which have facilitated concertation in some cases, but not in
others. Using a similar country design, the paper compares four continental
European countries with similar reform pressures but different reform trajectories:
France, Germany, Italy, and the Netherlands.Die Reform des Wohlfahrtsstaates erfordert VerÀnderungen in interdependenten
Politikfeldern, von der Sozialpolitik bis hin zur BeschÀftigungs- und Lohnpolitik.
Diese interdependenten Politikfelder werden von unterschiedlichen Konstellationen
korporativer und politischer Akteure kontrolliert und sind unterschiedlichen
Verfahren der Entscheidungsfindung unterworfen. Adaptionen in einem
Sektor sind hÀufig nicht mit anderen politischen Entscheidungen koordiniert
und können somit negative Auswirkungen haben oder aufgrund der ungĂŒnstigen
Grundbedingungen fehlschlagen.
In dem vorliegenden Discussion Paper wird zunÀchst argumentiert, daà die
Notwendigkeit, politische Entscheidungen ĂŒber die Grenzen der politischen Sektoren
hinaus zu koordinieren, zu einer Renaissance dreiseitiger Konzertierung
zwischen Tarifparteien und Regierungen gefĂŒhrt hat. Weiterhin werden die institutionellen
Faktoren herausgearbeitet, die eine Konzertierung in einigen FĂ€llen
ermöglicht haben, in anderen jedoch nicht. Es werden vier LÀnder verglichen, die
Àhnliche Strukturen und ReformzwÀnge aufweisen, aber unterschiedliche Lösungswege
gewÀhlt haben: Frankreich, Deutschland, Italien und die Niederlande
Binary Interactions and Starch Bioavailability: Critical in Limiting Glycemic Response
Limiting starch bioavailability by modifying food matrix dynamics has evolved over the decade, which further envisions low glycemic starch prototypes to tackle chronic hyperglycemia. The dense matrix of whole grain foods like millets and cereals act as a suitable model to understand the dynamics of binary food matrix interactions between starch-lipid, starch-protein & starch-fiber. The state and types of matrix component (lipid/protein/fiber) which interact at various scales alters the starch micro configuration and limits the digestibility, but the mechanism is largely been ignored. Various in-vitro and in-vivo studies have deciphered the varied dimensions of physical interactions through depletion or augmentation studies to correlate towards a natural matrix and its low glycemic nature. The current chapter briefly encompasses the concept of food matrix types and binary interactions in mediating the glycemic amplitude of starch. We comprehensively elaborated and conceptually explained various approaches, which investigated the role of food matrices as complex real food systems or as fundamental approaches to defining the mechanisms. Itâs a fact that multiple food matrix interaction studies at a time are difficult but itâs critical to understand the molecular interaction of matrix components to correlate in-vivo processes, which will assist in designing novel food prototypes in the future
Erratum: ICTV Virus taxonomy profile: Potyviridae
No abstract availabl
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990â2019 : A systematic analysis for the Global Burden of Disease Study 2019
Background
Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages.
Methods
Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (â„65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0â100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion targetâ1 billion more people benefiting from UHC by 2023âwe estimated additional population equivalents with UHC effective coverage from 2018 to 2023.
Findings
Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2â47·5) in 1990 to 60·3 (58·7â61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9â3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010â2019 relative to 1990â2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6â421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0â3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5â1040·3]) residing in south Asia.
Interpretation
The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all peopleâthe ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how closeâor how farâall populations are in benefiting from UHC
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990â2019: a systematic analysis for the Global Burden of Disease Study 2019
Background
Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages.
Methods
Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (â„65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0â100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion targetâ1 billion more people benefiting from UHC by 2023âwe estimated additional population equivalents with UHC effective coverage from 2018 to 2023.
Findings
Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2â47·5) in 1990 to 60·3 (58·7â61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9â3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010â2019 relative to 1990â2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6â421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0â3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5â1040·3]) residing in south Asia.
Interpretation
The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all peopleâthe ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how closeâor how farâall populations are in benefiting from UHC
Global burden of 369 diseases and injuries in 204 countries and territories, 1990â2019: a systematic analysis for the Global Burden of Disease Study 2019
Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990â2010 time period, with the greatest annualised rate of decline occurring in the 0â9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10â24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10â24 years were also in the top ten in the 25â49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50â74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019 : a comprehensive demographic analysis for the Global Burden of Disease Study 2019
Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019.
Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10â14 and 50â54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66â2·79) in 2000 to 2·31 (2·17â2·46) in 2019. Global annual livebirths increased from 134·5 million (131·5â137·8) in 2000 to a peak of 139·6 million (133·0â146·9) in 2016. Global livebirths then declined to 135·3 million (127·2â144·1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2·1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27·1% (95% UI 26·4â27·8) of global livebirths. Global life expectancy at birth increased from 67·2 years (95% UI 66·8â67·6) in 2000 to 73·5 years (72·8â74·3) in 2019. The total number of deaths increased from 50·7 million (49·5â51·9) in 2000 to 56·5 million (53·7â59·2) in 2019. Under-5 deaths declined from 9·6 million (9·1â10·3) in 2000 to 5·0 million (4·3â6·0) in 2019. Global population increased by 25·7%, from 6·2 billion (6·0â6·3) in 2000 to 7·7 billion (7·5â8·0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58·6 years (56·1â60·8) in 2000 to 63·5 years (60·8â66·1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019
- âŠ